1 Number That Should Shock Fulgent Genetics Investors

Jason Hawthorne, The Motley Fool
·4 min read
1 Number That Should Shock Fulgent Genetics Investors

Shareholders of Fulgent Genetics (NASDAQ: FLGT) have been on quite a ride over the past year. The diagnostics company has subjected investors to both euphoria and despair. COVID-19 ushered in an era of testing that propelled shares to huge gains, and the authorization of vaccines convinced Wall Street the boom was behind us.